Immune-Related lncRNA to Construct Novel Signature and Predict the Immune Landscape of Human Hepatocellular Carcinoma
Top Cited Papers
Open Access
- 9 October 2020
- journal article
- research article
- Published by Elsevier BV in Molecular Therapy Nucleic Acids
- Vol. 22, 937-947
- https://doi.org/10.1016/j.omtn.2020.10.002
Abstract
No abstract availableFunding Information
- Natural Science Foundation of Guangdong Province for Distinguished Young Scholars
This publication has 57 references indexed in Scilit:
- Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression dataeLife, 2017
- TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune CellsCancer Research, 2017
- Gene regulation in the immune system by long noncoding RNAsNature Immunology, 2017
- Increased HAGLR expression promotes non–small cell lung cancer proliferation and invasion via enhanced de novo lipogenesisTumor Biology, 2017
- Immunobiology of Long Noncoding RNAsAnnual Review of Immunology, 2017
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trialThe Lancet, 2017
- Long Noncoding RNAs in Cancer PathwaysCancer Cell, 2016
- Cancer statistics in China, 2015CA: A Cancer Journal for Clinicians, 2016
- Long noncoding RNAs and their role in the liver cancer axisNature Reviews Gastroenterology & Hepatology, 2013
- ColoGuidePro: A Prognostic 7-Gene Expression Signature for Stage III Colorectal Cancer PatientsClinical Cancer Research, 2012